BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

The results revealed that taking both doses of Pfizer's COVID-19 vaccine led to fewer endothelial cells in the eye and ...

Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...

A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...

Pfizer and BioNTech have asked the Food and Drug Administration to greenlight a fourth dose of their COVID-19 vaccine for Americans 65 and older, the companies announced Tuesday, citing data from ...

Pfizer also said it is working to improve its existing vaccine formulation, developed jointly with Germany's BioNTech, based on the vaccine's reaction to new COVID-19 variants that arise.

Pfizer is also looking to expand its vaccine business following the pandemic, extending its use of the gene-based mRNA technology which has proved highly effective in the Covid-19 vaccines.

Anyone 50 or older who has gotten any approved or authorized primary COVID-19 vaccine series and a booster dose is eligible for a second booster of Pfizer-BioNTech or Moderna at least four months ...

A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated photograph.

In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data.

Kids ages 5 to 11 will soon be able to get Pfizer's low-dose COVID vaccine. CDC director Rochelle Walensky agreed with a unanimous decision of a team of advisers that the benefits outweigh the risks.